When does Hemlibra’s patent expire?
Hemlibra (emicizumab) is protected by multiple patents, so the “expiration date” depends on which specific patent(s) you mean. Based on publicly reported patent information, Hemlibra’s key patent protections extend into the early 2030s rather than expiring in the near term. [1]
DrugPatentWatch.com tracks patent status across filings and provides timelines by patent family, which is the most practical way to pinpoint the relevant expiration for a given use. [1]
Why there isn’t one single Hemlibra expiration date
Because Hemlibra has several patent families (for example, covering different aspects such as the molecule and related formulations/uses), different patents can expire on different dates. Patent expiration for one patent may not equal the end of exclusivity for the product overall. [1]
What happens after patent expiration?
After the relevant patents expire, manufacturers may be able to pursue competition (including biosimilar pathways), depending on regulatory requirements and whether additional exclusivity or still-active patents cover aspects of the product. The exact timing can therefore shift based on litigation and the remaining patent estate. [1]
Where to check the exact date for the patent you care about
If you need the specific expiration date for a particular Hemlibra patent (not just the approximate window for major protections), DrugPatentWatch.com is designed to let you look up the relevant patent listings and their projected expiration dates. [1]
Sources:
[1] https://www.drugpatentwatch.com/